======= NPAT =======
== Gene Information ==
* **Official Symbol**: NPAT
* **Official Name**: nuclear protein, coactivator of histone transcription
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4863|4863]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q14207|Q14207]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=NPAT&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NPAT|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601448|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters. {ECO:0000269|PubMed:10995386, ECO:0000269|PubMed:10995387, ECO:0000269|PubMed:12665581, ECO:0000269|PubMed:12724424, ECO:0000269|PubMed:14585971, ECO:0000269|PubMed:14612403, ECO:0000269|PubMed:15555599, ECO:0000269|PubMed:15988025, ECO:0000269|PubMed:16131487, ECO:0000269|PubMed:17163457, ECO:0000269|PubMed:17826007, ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:17974976, ECO:0000269|PubMed:9472014}.
No Pfam Domain information is available for this gene.
|Gemini of coiled bodies|
|regulation of transcription involved in G1/S transition of mitotic cell cycle|
|Cajal body|
|transcription coregulator activity|
|protein N-terminus binding|
|G1/S transition of mitotic cell cycle|
|cell cycle G1/S phase transition|
|protein C-terminus binding|
|transcription corepressor activity|
|mitotic cell cycle phase transition|
|cell cycle phase transition|
|transcription coactivator activity|
|in utero embryonic development|
|mitotic cell cycle process|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|mitotic cell cycle|
|embryo development|
|cell cycle process|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|cell cycle|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|positive regulation of transcription, DNA-templated|
|negative regulation of biosynthetic process|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp530|Thioridazine 5μM R08 exp530]]|1.79|
|[[:results:exp375|Lenalidomide 20μM R07 exp375]]|2.04|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 173/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|7/28|
|blood|6/28|
|bone|6/25|
|breast|9/33|
|central nervous system|11/56|
|cervix|0/4|
|colorectal|2/17|
|esophagus|2/13|
|fibroblast|1/1|
|gastric|2/15|
|kidney|5/21|
|liver|8/20|
|lung|11/75|
|lymphocyte|1/14|
|ovary|10/26|
|pancreas|4/24|
|peripheral nervous system|8/16|
|plasma cell|2/15|
|prostate|1/1|
|skin|9/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|5/22|
|urinary tract|2/29|
|uterus|1/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2234
* **Expression level (log2 read counts)**: 6.05
{{:chemogenomics:nalm6 dist.png?nolink |}}